Biotech · Private company
BlackThorn Therapeutics, Inc.
Track this companyFree. Adds BlackThorn Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- BTRX-246040Phase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BTRX-246040 oral capsule(s)Phase 2 · Major Depressive DisorderClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- BTRX-246040 Study in Participants With Parkinson's Disease With Motor FluctuationsPHASE2 · COMPLETED · started Aug 31, 2018ClinicalTrials.gov NCT03608371 · fetched Nov 12, 2026
- BTRX-246040 Administered Once Daily to Patients With Major Depressive DisorderPHASE2 · COMPLETED · started Jun 12, 2017ClinicalTrials.gov NCT03193398 · fetched Nov 12, 2026